Additionally, antibody blockade of PD-1 or its ligands restored IgM secretion in TCDD-treated CD5+ B cells suggesting, for the first time, a direct role for PD-1 in TCDD-mediated immunotoxicity. The gene discussed is PDCD1; the disease is immune system toxicity.